|
|
|
|
|
|
Sponsored by: |
Pfizer |
Information provided by: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00034827 |
CI-1040 is an experimental drug that is being tested in patients who have advanced colorectal and lung cancer who failed no more than one prior chemotherapy regimen, breast cancer who have failed no more than 2 prior regimens and in patients with pancreatic cancer who have received no prior chemotherapy. CI-1040 is taken orally twice daily with meals. Patients are required to have blood tests periodically while receiving treatment and will be monitored closely throughout the trial for possible side effects and for response.
Condition | Intervention | Phase |
Colorectal Neoplasms Breast Neoplasms Carcinoma, Non-Small-Cell Lung Pancreatic Neoplasms |
Drug: CI-1040 |
Phase II |
Genetics Home Reference related topics: | breast cancer |
MedlinePlus related topics: | Breast Cancer Cancer Colorectal Cancer Lung Cancer Pancreatic Cancer |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer, or Pancreatic Cancer |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Alabama | |||||
Pfizer Investigational Site | |||||
Birmingham, Alabama, United States, 35205 | |||||
Pfizer Investigational Site | |||||
Birmingham, Alabama, United States, 35233 | |||||
United States, California | |||||
Pfizer Investigational Site | |||||
Los Angeles, California, United States, 90048 | |||||
Pfizer Investigational Site | |||||
Blendora, California, United States, 91740 | |||||
Pfizer Investigational Site | |||||
Glendale, California, United States, 91204 | |||||
Pfizer Investigational Site | |||||
Huntington Beach, California, United States, 92648 | |||||
Pfizer Investigational Site | |||||
Long Beach, California, United States, 90813 | |||||
Pfizer Investigational Site | |||||
Rancho Cucamonga, California, United States, 91730 | |||||
Pfizer Investigational Site | |||||
Los Angeles, California, United States, 90095 | |||||
Pfizer Investigational Site | |||||
Mission Hills, California, United States, 91345 | |||||
Pfizer Investigational Site | |||||
Northridge, California, United States, 91328 | |||||
Pfizer Investigational Site | |||||
Oxnard, California, United States, 93030 | |||||
Pfizer Investigational Site | |||||
Pasadena, California, United States, 91105 | |||||
Pfizer Investigational Site | |||||
Pomona, California, United States, 91767 | |||||
Pfizer Investigational Site | |||||
Los Alamitos, California, United States, 90720 | |||||
Pfizer Investigational Site | |||||
Redondo Beach, California, United States, 90277 | |||||
Pfizer Investigational Site | |||||
Santa Monica, California, United States, 90404 | |||||
Pfizer Investigational Site | |||||
Torrance, California, United States, 90505 | |||||
Pfizer Investigational Site | |||||
Ventura, California, United States, 93003 | |||||
Pfizer Investigational Site | |||||
West Covina, California, United States, 91790 | |||||
United States, Georgia | |||||
Pfizer Investigational Site | |||||
Atlanta, Georgia, United States, 30342 | |||||
Pfizer Investigational Site | |||||
Decatur, Georgia, United States, 30033 | |||||
Pfizer Investigational Site | |||||
Macon, Georgia, United States, 30342 | |||||
United States, Kentucky | |||||
Pfizer Investigational Site | |||||
Crestview Hills, Kentucky, United States, 41017 | |||||
United States, Michigan | |||||
Pfizer Investigational Site | |||||
Detroit, Michigan, United States, 48201 | |||||
United States, Minnesota | |||||
Pfizer Investigational Site | |||||
Rochester, Minnesota, United States, 55905 | |||||
United States, Ohio | |||||
Pfizer Investigational Site | |||||
Cincinnait, Ohio, United States, 45236 | |||||
Pfizer Investigational Site | |||||
Cincinnati, Ohio, United States, 45242 | |||||
Pfizer Investigational Site | |||||
Cincinnati, Ohio, United States, 45230 | |||||
Pfizer Investigational Site | |||||
Cincinnati, Ohio, United States, 45219 |
Pfizer |
Study Director: | Pfizer CT.gov Call Center | Pfizer |
To obtain contact information for a study center near you, click here. 
  |
Study ID Numbers: | 1040-000-002 |
First Received: | May 2, 2002 |
Last Updated: | May 3, 2007 |
ClinicalTrials.gov Identifier: | NCT00034827 |
Health Authority: | United States: Food and Drug Administration |
|
|
|